Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endoplasmic reticulum stress response elements (ERSEs) are consensus DNA motifs in the promoters of target genes that mediate transcriptional activation during the ER stress (unfolded protein) response[5][3]. Classic ERSEs (consensus: CCAAT-N9-CCACG) are recognized by activated ATF6 and XBP1 transcription factors, often in cooperation with the general transcription factor NF-Y[5][3]. Related motifs include ERSE-II (ATTGG-N-CCACG) and UPRE (TGACGTGG/A), which also mediate ER stress-induced gene expression. These DNA elements enable cells to upregulate chaperones and ER quality control machinery to restore protein folding homeostasis under stress conditions. ERSE-bearing genes are crucial for adapting to stress and are implicated in various diseases where ER dysfunction is central, but ERSE as a DNA sequence is not a direct therapeutic target[3][5].
N/A (not a drug target); transcription factors like ATF6 and XBP1 bind ERSEs to activate stress response genes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endoplasmic reticulum stress response element (ERSE).